Who owns ANI PHARMACEUTICALS INC?
- CUSIP Number: 00182cac7
Tip: Access positions for across all investors
Analyze quarterly positions in Ani Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ani Pharmaceuticals stock
Who bought or sold ANI PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Camden Asset Management | 43M | $54B | 13% | Dec 2025 |
|
| Alberta Investment Management Corporation | 30M | $38M | 100% | Dec 2025 |
|
| Empyrean Capital Partners | 23M | $32M | 100% | Sep 2025 |
|
| Millennium Management | 21M | $30M | 100% | Sep 2025 |
|
| Citadel Advisors | 20M | $27M | 100% | Sep 2025 |
|
| Absolute Investment Advisers | 12M | $15M | 0% | Dec 2025 |
|
| BlackRock | 11M | $14M | -60% | Dec 2025 |
|
| Context Capital Management | 10M | $13M | 100% | Dec 2025 |
|
| Jpmorgan Chase & Co | 9.3M | $13M | 100% | Sep 2025 |
|
| Leucadia National Corporation | 7.6M | $9.6M | 69% | Dec 2025 |
|
| Point72 Asset Management | 7.5M | $9.5M | 100% | Dec 2025 |
|
| Polar Securities | 6.0M | $8.4M | 100% | Sep 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 5.3M | $6.8M | 30% | Dec 2025 |
|
| Gabelli Funds | 5.1M | $6.4M | 0% | Dec 2025 |
|
| Susquehanna Advisors Group | 5.0M | $63k | 100% | Dec 2025 |
|
| Picton Mahoney Asset Management | 4.0M | $5.0M | 0% | Dec 2025 |
|
| FMR | 2.6M | $3.6M | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.5M | $1.9M | 40% | Dec 2025 |
|
| Goldman Sachs Group | 1.5M | $1.9M | 100% | Dec 2025 |
|
| Lazard Asset Management | 960k | $12k | -88% | Dec 2025 |
|
| Bank of New York Mellon | 850k | $1.1M | 21% | Dec 2025 |
|
| Calamos Advisors | 39k | $49k | 34% | Dec 2025 |
|
| Boussard & Gavaudan Investment Management | 19k | $24M | 85% | Dec 2025 |
|
Who sold out of Ani Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2025 | 71M | $100M |
| Jain Global | Sep 2025 | 2.5M | $3.5M |
| Jane Street | Sep 2025 | 50k | $71k |